Lexcel Launches AI Operating System to Transform Specialty Insurance Underwriting
By Lauren Towner · 15 October 2026

Lexcel has launched an AI operating system specifically for specialty insurance underwriting. For carriers and MGAs, this addresses the consistency issues inherent in high-volume, complex risk environments by codifying firm-specific guidelines and precedent into an automated triage and drafting workflow, allowing underwriters to maintain authority while scaling their operations without increasing headcount.
What was announced
Lexcel has introduced an AI operating system tailored for the specialty insurance market, focusing on the preservation and application of institutional knowledge. The platform is designed to automate the triage and processing of broker submissions while ensuring that every decision aligns with a firm’s specific underwriting guidelines and historical precedents. The system operates through three integrated modules: Intake, Workbench, and Workflows.
The Intake module automatically reads incoming submissions, verifies data against source documentation, and routes risks according to the team’s specific appetite rules. The Workbench serves as a centralized record for each risk, updating automatically from the initial submission through to binding and potential claims, supported by live dashboards. Finally, the Workflows module applies the firm’s internal rules to draft submission overviews, quotes, and proposed terms, providing citations for every data point to its source document.
This setup allows underwriters to review and approve work rather than starting from scratch, with every decision made feeding back into the platform to build a library of precedent. Lexcel is currently deployed with specialty MGAs and is built to connect with existing core systems, removing the need for firms to employ in-house AI engineers or replace their existing systems of record. The platform aims to turn individual expertise into a compounding foundation that the entire underwriting team can utilize.
The companies involved
Lexcel is a technology provider focused on the specialty insurance sector. The company is led by Co-founder and Chief Executive Officer David Stepovich, who brings a background as a former M&A attorney at the law firm Latham & Watkins. This legal background informs the platform’s emphasis on precedent, citations, and the rigorous application of complex rules—elements that are critical in specialty lines where policy wording and historical intent often dictate the success of a book of business.
Lexcel positions itself as a partner for firms that lack the internal resources to build bespoke AI infrastructure but require sophisticated tools to manage high-volume, high-complexity risks. By focusing on the "operating system" model, the company aims to sit atop existing systems of record, providing a layer of intelligence that captures the expert judgment often siloed within senior underwriting staff. The firm’s current market footprint includes partnerships with specialty Managing General Agents (MGAs), where the need for rapid triage and consistent adherence to capacity provider guidelines is paramount for maintaining long-term underwriting profitability.
What this means from an insurtech perspective
This launch highlights a shift in the insurtech narrative from generic efficiency to the preservation of intellectual property. In specialty lines, the "underwriting gut" is often a firm’s greatest asset but also its biggest bottleneck. By codifying this judgment, Lexcel is addressing the key risk of inconsistent loss ratios that often plague MGAs and carriers during periods of rapid growth. For the broader market, this puts pressure on legacy core-system vendors who have struggled to provide the granular, rule-based automation required for complex risks. It also suggests a move away from "black box" AI toward "glass box" systems where every automated suggestion is cited to a source document. This transparency is essential for regulatory compliance and maintaining the trust of reinsurers who provide the capital behind these specialty risks.
Companies in this story: Lexcel
People in this story: David Stepovich